Hap Trading, LLC Brooklyn Immuno Therapeutics, Inc. Transaction History
Hap Trading, LLC
- $872 Billion
- Q3 2024
A detailed history of Hap Trading, LLC transactions in Brooklyn Immuno Therapeutics, Inc. stock. As of the latest transaction made, Hap Trading, LLC holds 11,800 shares of BTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,800Holding current value
$0% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BTX
# of Institutions
1Shares Held
1.21MCall Options Held
0Put Options Held
0About Brooklyn ImmunoTherapeutics, Inc.
- Ticker BTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,825,700
- Description
- Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy techno...